• 1
    Benè, M., Castoldi, G.L., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A., Van't Veer, M.B., on behalf of the European Group for the Immunological Characterization of Leukemias, EGIL (1995) Proposals for the immunological classification of acute leukemias. Leukemia, 9, 1783 1786.
  • 2
    Bennett, B., Croll, A.M., Robbie, L.A., Herriot, R. (1997) Tumour cell u-PA as a cause of fibrinolytic bleeding in metastatic disease. British Journal of Haematology, 99, 570 574.
  • 3
    Borregaard, N. & Cowland, J. (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood, 89, 3503 3521.
  • 4
    Bu, G., Warshawsky, I., Schwartz, A.L. (1994) Cellular receptors for the plasminogen activators. Blood, 83, 3427 3436.
  • 5
    Cao, D., Mizukani, I.F., Garni-Wagner, B.A., Kindzelsky, A.L., Todd, R.F. (1995) Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release: possible roles of complement receptor type 3 and calcium. Journal of Immunology, 154, 1817 1829.
  • 6
    Castoldi, G.L. & Cuneo, A. (1996) Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes. Acute Myelogenous Leukaemia and Myelodysplasia (ed. by B. Lowemberg), pp. 19 32. Baillière Tindall, London.
  • 7
    Gadd, S., Majdic, O., Kasinrerk, W., Stockinger, H., Maurer, D., Eher, D., Knapp, W. (1990) M5, a phosphoinositol linked human myelo-monocytic activation associated antigen. Clinical and Experimental Immunology, 80, 252 256.
  • 8
    Garni-Wagner, B.A. & Todd, R.F. (1995) Two epitopes within the ligand binding domain in the human urokinase receptor are defined by select mAb. Leukocyte Typing V: White Cell Differentiation Antigens (ed. by S. F. Schlossman et al), Vol. 1, pp. 945 949. Oxford University Press.
  • 9
    Gyetko, M.R., Chen, G.H., McDonald, R.A., Goodman, R., Huffnagle, G.B., Willkinson, C.C., Fuller, J.A., Toews, G.B. (1996) Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model . Journal of Clinical Investigation, 97, 1818 1826.
  • 10
    Gyetko, M.R., Sitrin, R.G., Fuller, J., Todd, R.F., III, Petty, H., Standiford, T.J. (1995) Function of the urokinase receptor (CD87) in neutrophil chemotaxis. Journal of Leukocyte Biology, 58, 533 538.
  • 11
    Gyetko, M.R., Todd, R.F., Wilkinson, C.C., Sitrin, R.G. (1994) The urokinase receptor is required for human monocyte chemotaxis in vitro. Journal of Clinical Investigation, 93, 1380 1387.
  • 12
    Kindzelskii, A.L., Laska, Z.O., Todd, R.F., Petty, H.R. (1996) Urokinase-type plasminogen activator receptor recversibly dissociates from complement receptor type III (alpha M beta 2′ CD11b/CD18) during neutrophil polarization. Journal of Immunology, 156, 297 309.
  • 13
    Knapp, W., Strobl, H., Majdic, O. (1994) Flow cytometric analysis of cell surface and intracellular antigens in leukemia diagnosis. Cytometry, 18, 187 198.
  • 14
    Lanza, F., Bi, S., Godman, J.M. (1993) Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia, 7, 1570 1575.
  • 15
    Lanza, F., Campana, D., Knapp, W., Janossy, G., Lacombe, F., Matutes, E., Orfao, A., Schmitz, G. (1996) Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results?. European Journal of Histochemistry, 40, 7 14.
  • 16
    Lanza, F., Castagnari, B., Rigolin, G.M., Moretti, S., Ferrari, L., Bardi, A., Castoldi, G.L. (1997a)Flow cytometry measurement of GM-CSF receptors in acute leukemic blasts, and normal hemopoietic cells. Leukemia, 11, 1700 1710.
  • 17
    Lanza, F., Latorraca, A., Moretti, S., Castagnari, B., Ferrari, L., Castoldi, G.L. (1997b)Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Cytometry, 30, 134 144.
  • 18
    Lanza, F., Moretti, S., Papa, S., Malavasi, F., Castoldi, G.L. (1994) Report on the Fifth International Workshop on Human Leukocyte Differentiation Antigens, Boston, 3–7 November, 1993. Haematologica, 79, 374 387.
  • 19
    Lanza, F, Sucai, B., Moretti, S., Castoldi, G.L., Godman, J.M. (1995) Modulation of cell kinetics and cell cycle status by treating chronic myeloid leukaemia CD34+ cells with p53 antisense phophorothioate oligonucleotides. British Journal of Haematology, 90, 8 14.
  • 20
    Lijnen, H.R. (1996) Pathophysiology of the plasminogen–plasmin system. International Journal of Clinical and Laboratory Research, 26, 1 6.
  • 21
    Mizukami, I., Vinjamuri, S., Trochelman, D., Todd, R. (1990) Structural characterization of the Mo3 activation antigen expressed on the plasma membrane of human polymorphonuclear phagocytes. Journal of Immunology, 144, 1841 1848.
  • 22
    Papa, S. & Lanza, F. (1996) Immunophenotyping Hematological Malignancies. Luigi & Ponzio Editore, Pavia.
  • 23
    Plesner, T., Ploug, M., Ellis, V., Ronne, E., Hoyer-Hansen, G., Wittrup, M., Pedersen, T.L., Tscherning, T., Dano, K., Hansen, N.E. (1994) The receptor for urokinase type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils. Blood, 83, 808 815.
  • 24
    Poncelet, P., George, F., Papa, S., Lanza, F. (1996) Quantitation of hemopoietic cell antigens in flow cytometry. European Journal of Histochemistry, 40, 15 32.
  • 25
    Pyke, C., Kristensen, P., Ralfkiaer, E., Grondahl-Hansen, J., Eriksen, J., Blasi, F., Dano, K. (1991) Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. American Journal of Pathology, 138, 1059 1065.
  • 26
    Simon, D., Rao, N., Xu, H., Wei, Y., Majdic, O., Ronne, E., Kobzik, L., Chapman, H. (1996) Mac-1 (CD11b/ CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood, 88, 3185 3194.
  • 27
    Sitrin, R.G., Todd, R.F., III, Mizukami, I.F., Gross, T.J., Shollenberger, S.B., Gyetko, M.R. (1994) Cytokine-specific regulation of urokinase receptor (CD87) expression by U937 mononuclear phagocytes. Blood, 84, 1268 1275.
  • 28
    Spisani, S., Pareschi, M.C., Buzzi, M., Colamussi, M.L., Biondi, C., Traniello, S., Pagani Zecchini, G., Paglialunga Paradisi, M., Torrini, I., Ferretti, M.E. (1996) Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides. Cellular Signaling, 8, 269 277.
  • 29
    Spisani, S., Traniello, S., Martuccio, T., Rizzuti, O., Cellai, L. (1997) Ryfamycin inhibit human neutrophil functions: new derivatives with potential antiinflammatory activity. Inflammation, 21, 391 400.
  • 30
    Stephens, R., Tapiovaara, H., Alitalo, R., Reisberg, T., Lymboussakis, A., Myohanen, H., Vaheri, A. (1992) Cell surface plasminogen activation and leukemia. Fibrinolysis, 6, 35 39.
  • 31
    Todd, R., III & Petty, H. (1997) β2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors. Journal of Laboratory and Clinical Medicine, 129, 492 498.
  • 32
    Todd, R.F., Barnathan, E.S., Bohuslav, J., Chapman, A., Cohen, R.L., Felez, J., Howell, J., Johnson, J.G., Knapp, W., Kramer, M., Miles, L.A., Nykjaer, A., Ralkiaer, E., Schuren, E. (1995) CD87 cluster workshop report. Leukocyte Typing V: White Cell Differentiation Antigens (ed. by S. F. Schlossman et al), Vol. 1, pp. 932 939. Oxford University Press.
  • 33
    Wei, Y., Lukashev, M., Simon, D.I., Bodary, S.C., Rosenberg, S., Doyle, M.V., Chapman, H.A. (1996) Regulation of integrin function by the urokinase receptor. Science, 273, 1551 1555.
  • 34
    Xue, W., Kindzelskii, A.L., Todd, R.F., Petti, H.R. (1994) Physical association of complement receptor type 3 and urokinase type plasminogen activator receptor in neutrophil membranes. Journal of Immunology, 152, 4630 4638.
  • 35
    Ye, R.D. & Boulay, F. (1997) Structure and function of leukocyte chemoattractant receptors. Advances in Pharmacology, 39, 221 289.
  • 36
    Zigmond, S.H. & Hirsch, J.G. (1973) Leukocyte locomotion and chemotaxis, new method for evaluation and demonstration of a cell-derived chemotactic factor. Journal of Experimental Medicine, 137, 387 410.